224 related articles for article (PubMed ID: 26875783)
1. Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles.
Rodzinski A; Guduru R; Liang P; Hadjikhani A; Stewart T; Stimphil E; Runowicz C; Cote R; Altman N; Datar R; Khizroev S
Sci Rep; 2016 Feb; 6():20867. PubMed ID: 26875783
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner.
Taylor RM; Sillerud LO
Int J Nanomedicine; 2012; 7():4341-52. PubMed ID: 22915856
[TBL] [Abstract][Full Text] [Related]
3. Magneto-electric nanoparticles to enable field-controlled high-specificity drug delivery to eradicate ovarian cancer cells.
Guduru R; Liang P; Runowicz C; Nair M; Atluri V; Khizroev S
Sci Rep; 2013 Oct; 3():2953. PubMed ID: 24129652
[TBL] [Abstract][Full Text] [Related]
4. Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields.
Stewart TS; Nagesetti A; Guduru R; Liang P; Stimphil E; Hadjikhani A; Salgueiro L; Horstmyer J; Cai R; Schally A; Khizroev S
Nanomedicine (Lond); 2018 Feb; 13(4):423-438. PubMed ID: 29345190
[TBL] [Abstract][Full Text] [Related]
5. Novel free paclitaxel-loaded poly(L-γ-glutamylglutamine)-paclitaxel nanoparticles.
Yang D; Van S; Jiang X; Yu L
Int J Nanomedicine; 2011 Jan; 6():85-91. PubMed ID: 21289985
[TBL] [Abstract][Full Text] [Related]
6. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution and clearance of magnetoelectric nanoparticles for nanomedical applications using energy dispersive spectroscopy.
Hadjikhani A; Rodzinski A; Wang P; Nagesetti A; Guduru R; Liang P; Runowicz C; Shahbazmohamadi S; Khizroev S
Nanomedicine (Lond); 2017 Aug; 12(15):1801-1822. PubMed ID: 28705034
[TBL] [Abstract][Full Text] [Related]
8. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.
Xiao K; Li Y; Lee JS; Gonik AM; Dong T; Fung G; Sanchez E; Xing L; Cheng HR; Luo J; Lam KS
Cancer Res; 2012 Apr; 72(8):2100-10. PubMed ID: 22396491
[TBL] [Abstract][Full Text] [Related]
9. Application of Paclitaxel-loaded EGFR Peptide-conjugated Magnetic Polymeric Liposomes for Liver Cancer Therapy.
Lin ZL; Ding J; Sun GP; Li D; He SS; Liang XF; Huang XR; Xie J
Curr Med Sci; 2020 Feb; 40(1):145-154. PubMed ID: 32166677
[TBL] [Abstract][Full Text] [Related]
10. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.
Li Y; Xiao K; Luo J; Xiao W; Lee JS; Gonik AM; Kato J; Dong TA; Lam KS
Biomaterials; 2011 Sep; 32(27):6633-45. PubMed ID: 21658763
[TBL] [Abstract][Full Text] [Related]
11. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
Lv W; Cheng L; Li B
Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
[TBL] [Abstract][Full Text] [Related]
13. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone inhibits the effect of paclitaxel on human ovarian carcinoma xenografts in nude mice.
Hou WJ; Guan JH; Dong Q; Han YH; Zhang R
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2902-8. PubMed ID: 24254559
[TBL] [Abstract][Full Text] [Related]
15. Multistimuli-Regulated Photochemothermal Cancer Therapy Remotely Controlled via Fe5C2 Nanoparticles.
Yu J; Ju Y; Zhao L; Chu X; Yang W; Tian Y; Sheng F; Lin J; Liu F; Dong Y; Hou Y
ACS Nano; 2016 Jan; 10(1):159-69. PubMed ID: 26602632
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
[TBL] [Abstract][Full Text] [Related]
17. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
Mitra M; Misra R; Harilal A; Sahoo SK; Krishnakumar S
Mol Vis; 2011; 17():2724-37. PubMed ID: 22065926
[TBL] [Abstract][Full Text] [Related]
18. Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapy.
Dwivedi P; Han S; Mangrio F; Fan R; Dwivedi M; Zhu Z; Huang F; Wu Q; Khatik R; Cohn DE; Si T; Hu S; Sparreboom A; Xu RX
Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():113-123. PubMed ID: 31146981
[TBL] [Abstract][Full Text] [Related]
19. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
